Validation of the VITEK2 and the Advance Expert System with a collection of Enterobacteriaceae harboring extended spectrum or inhibitor resistant β-lactamases

Diagnostic Microbiology and Infectious Disease

Volumn 41, Issue 1-2, 2001, Pages 65-70

  Cantón, Rafael ^a   Pérez Vázquez, María ^a   Oliver, Antonio ^a   Coque, Teresa M ^a   Loza, Elena ^a   Ponz, Francisco ^a   Baquero, Fernando ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CEFUROXIME; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ACCURACY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; DILUTION; ENTEROBACTERIACEAE; ENZYME INHIBITION; EVALUATION; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SPECTRUM; TECHNIQUE; VALIDATION PROCESS;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; ENTEROBACTERIACEAE; EXPERT SYSTEMS; MICROBIAL SENSITIVITY TESTS;

EID: 0034778162     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(01)00286-3     Document Type: Article

References (36)

1. The advanced expert system. A new approach to antimicrobial susceptibility testing interpretation
2. CTX-M-5, a novel cefotaxime-hydrolyzing β-lactamase from an outbreak of Salmonella typhimurium in Latvia
3. A functional classification scheme for β-lactamases and its correlation with molecular structure
4. Detection of extended-spectrum β-lactamase (ESBL)-producing strains by Etest ESBL screen
5. Occurrence and detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae at a veterans medical center: Seek and you may find
6. Verification and validation of procedures in the Clinical Microbiology Laboratory
7. Detection and clinical significance of extended-spectrum β-lactamases in a tertiary-care medical center
8. Laboratory detection of extended-spectrum β-lactamasese (ESBLs) - The need for a reliable, reproducible method
9. Susceptibility testing instrumentation and computerized expert systems for data analysis and interpretation
10. Extended spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns
11. Evaluation of the Vitek system to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepime
12. Selection criteria for an antimicrobial susceptibility testing system
13. Antimicrobial susceptibility testing: General principles and contemporary practices
14. Antimicrobial susceptibility testing: Special needs for fastidious organisms and difficult-to-detect resistance mechanisms
15. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum β-lactamases
16. PCR detection and identification of genes for extended-spectrum β-lactamases
17. Roles of β-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae
18. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins
19. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of β-lactamase production among Escherichia coli and Klebsiella pneumoniae with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
20. New extended-spectrum TEM-type β-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak
21. Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing β-lactamase (CTX-M-10) isolated in Spain
22. Performance of the VITEK2 System for identification and susceptibility testing of routine Enterobacteriaceae clinical isolates
23. Origin and impact of plasmid-mediated extende-spectrum β-lactamasases
24. Evolution of extended-spectrum β-lactam-resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia
25. Cefepime: The next generation?
26. Detection of extended-spectrum-β-lactamase-producing members of the family Enterobacteriaceae with Vitek ESBL test
27. Ability of the VITEK2 advance expert system to identify β-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa
28. Salmonella enterica serovar Virchow with CTX-M-like β-lactamase in Spain
29. Detection and reporting of organisms producing extended-spectrum β-lactamases: Survey of laboratories in Connecticut
30. Controversies about extended-spectrum and AmpC β-lactamases
31. Detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae, comparison of the double-disk and three-dimensional test
32. CTX-M-type β-lactamases: An emerging group of extended-spectrum enzymes
33. Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas and the Western Pacific Region